Presentation: Selective p38mapk Isoform Expression and Activation in Anca-Associated Crescentic Glomerulonephritis (2007)

2003 Selective p38mapk Isoform Expression and Activation in Anca-Associated Crescentic Glomerulonephritis

Purpose. Crescentic glomerulonephritis (crGN) is a frequent and life-threatening manifestation of ANCA-associated vasculitis. Activation of pro-inflammatory cytokines contributes to renal damage by activation of p38MAPKs. However, it is unclear which of the four known p38MAPK isoforms are expressed, activated and hence of major importance in crGN.
Methods. Renal biopsy specimens of patients with ANCA-associated vasculitis and crGN and control samples were investigated for the expression and phosphorylation of p38MAPK isoforms and downstream target kinase MAPKAP2 by immunohistochemistry. Expression and functional activation of p38MAPK isoforms by TNF was also assessed in a human podocyte cell line by RT-PCR, immunoblotting and kinase array.
Results. Strong expression of p38MAPK α, β and γ isoforms was found in glomerular podocytes and crescents. Infiltrating leukocytes showed predominant p38MAPKα expression. Activation of p38MAPK and its downstream mediator MAPKAP2 was found in crGN confined to glomerular podocytes, crescents and inflammatory infiltrates. Interestingly, kidney biopsies of corticosteroid-treated compared to untreated crescentic glomerulonephritis patients showed significantly lower p38MAPK activation. Activated p38MAPK co-localized with α, β and γ isoforms in podocytes and crescents, whilst leukocytes showed mainly p38MAPK α activation. In a human podocyte cell line mRNA and protein of all 4 p38MAPK isoforms was expressed but only p38MAPKα was activated upon challenge with TNF.
Conclusion. This study shows selective p38MAPK isoform expression and activation in crGN. Podocytes and podocyte- induce crescent formation is the main source of p38MAPK activation in crGN. TNF is a potent and selective activator of the α-isoform in podocytes, which therefore appears as a main contributor to proinflammatory signalling in the glomerulum of crGN.

 K. Polzer, None; A. Soleiman, None; W. Baum, None; J. Distler, None; R. Axmann, None; K. Redlich, None; G. Kroenke, None; G. Schett, None; J. Zwerina, Vasculitis Foundation, 2.